All Deals
February 27, 2025 - Deals
Ahmed Shafik Purchases Property From VennPoint Real Estate
Venn, a Toronto-based business banking and expense management startup, raised $15M in Series A funding led by Left Lane Capital, with participation from XYZ Venture Capital, Intact Ventures, and Gradient. Co-CEO Ahmed Shafik, a former Revolut executive, sees Canada as lagging behind the U.S. in banking and spend software innovation. Originally focused on international transfers and multi-currency accounts, Venn now serves 4,000 SMBs with corporate cards, expense automation, and accounting integrations. The company plans to expand into credit card payment acceptance and lending.
INVESTORS: Left Lane Capital, XYZ Venture Capital, Intact Ventures & Gradient
ROUND: Series A
AMOUNT: $15,000,000
HQ: #Toronto #Canada
#VentureCapital #Venn #LeftLaneCapital #XYZVentureCapital #IntactVentures #AhmedShafik #Gradient #TradedVC
More Deals
View All
Colossal Biosciences In Talks For Funding Round Targeting $23 Billion ValuationColossal Biosciences, the de-extinction biotech startup known for its efforts to recreate the woolly mammoth and other extinct species, is reportedly in talks to raise new funding at a valuation of roughly $23 billion–$24 billion, according to Axios. The potential raise would mark a significant jump for the five-year-old company, with investors valuing not only its genetic-engineering programs but also its broader genomics, reproductive technology, conservation, and intellectual property platform. Colossal has begun generating revenue through conservation technology sales and technology spinouts, including Astromech, an AI-driven predictive modeling company, and Form Bio, a computational biology platform, expanding its value beyond de-extinction efforts.
FOUNDERS: Ben Lamm & George Church
TARGET VALUATION: $23,000,000,000
HQ: Dallas, Texas
#VentureCapital #ColossalBiosciences #BenLamm #GeorgeChurch #TradedVC